First-pass extracted concept

chemokines

Candidate: concept label1 source documents5 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Chemokines are described as small chemotactic cytokines involved in chemotaxis, leukocyte and macrophage migration, inflammatory propagation, and brain-relevant neuroimmune functions.

Source 1DOI PubMed

Resources required

The abstract supports their use as a biological concept for serum biomarker studies and CNS pathophysiology analysis, but does not specify a particular assay platform or intervention format.

Source 1DOI PubMed

What problem it solves

They provide a candidate link between chronic inflammation and depressive disorder biology, including both peripheral and CNS-associated mechanisms.

Source 1DOI PubMed

What it does not solve

The review does not claim that chemokines alone explain MDD pathogenesis, and it notes substantial heterogeneity across biomarker studies.

Source 1DOI PubMed

Alternatives

The abstract contrasts chemokine-centered explanations with other proposed MDD mechanisms including monoaminergic neurotransmission changes, excitatory/inhibitory imbalance, HPA-axis hyperactivity, and abnormal neurogenesis.

Source 1DOI PubMed

Evidence Snippets

Recent findings have implicated a related family of cytokines with chemotactic properties, known collectively as chemokines, in many neuroimmune processes relevant to psychiatric disorders.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2019International Journal of Molecular SciencesDOI PubMed

1 evidence snippet 5 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1biomarker potentialsupports2019Source 1DOI PubMed

Elevated levels of chemokines have been detected in patient-derived serum from individuals with major depressive disorder, bipolar disorder, and schizophrenia.

Claim 2disease associationsupports2019Source 1DOI PubMed

Chronic inflammation is associated with major depressive disorder.

Claim 3evidence synthesissupports2019Source 1DOI PubMed

Existing biomarker studies support an important role for chemokines in the pathophysiology of psychiatric disorders despite heterogeneity of samples and methodologies.

Claim 4mechanistic rolesupports2019Source 1DOI PubMed

Chemokines are implicated in neuroimmune processes relevant to psychiatric disorders and have brain-specific functions including modulation of neuroendocrine functions, chemotaxis, cell adhesion, and neuroinflammation.

Claim 5translational potentialsupports2019Source 1DOI PubMed

Chemokines could be considered as possible peripheral markers of psychiatric disorders and as targets for treating depressive disorders.